Basic & Clinical Medicine ›› 2024, Vol. 44 ›› Issue (11): 1594-1597.doi: 10.16352/j.issn.1001-6325.2024.11.1594

• Mini Reviews • Previous Articles     Next Articles

Advances in the role of fibroblasts in gastroesophageal reflux disease

WANG Wei1, SUN Yongshun2*   

  1. 1. Shanghai University of Chinese Medicine,Shanghai 201203;
    2. Department of Spleen and Gastroenterology, Shanghai Municipul Hospital of Traditional Chinese Medicine,Shanghai 200071, China
  • Received:2024-01-30 Revised:2024-05-11 Online:2024-11-05 Published:2024-10-31
  • Contact: *sunyongshun@shutcm.edu.cn

Abstract: Esophageal damage in gastroesophageal reflux disease (GERD) is a chronic inflammation, and fibroblasts, as esophageal stromal cells, play an important role in the oesophageal mucosal barrier and oesophageal inflammation. Fibroblasts are closely associated with the degree of disease progression in GERD, secreting large amounts of collagen to promote oesophageal mucosal barrier repair during oesophageal damage, regulating immune homeostasis through paracrine signaling, and interacting with immune cells. In addition to secreting inflammatory products, but inappropriate fibroblast activation can induce a pro-inflammatory response. Activation of fibroblasts induces pro-inflammatory and immunosuppressive properties promoting the presence of disease, suggesting that they may play a key role in disease progression.

Key words: gastroesophageal reflux disease, fibroblast, esophageal mucosa, esophageal inflammation

CLC Number: